Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Bluejay Diagnostics, Inc.

  • ACTON, Massachusetts
  • Public · NASDAQ: BJDX
  • 6 employees
$5.0MMarket cap
$249.0KRevenue · FY2022
-$6.8MNet income
6Employees
BJDXNASDAQ
2021IPO

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2022
$249.0K
Net income
-$6.8M
Total assets
$7.1M
Market cap
$5.0M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: BJDX

15-minute delayed · data by Polygon.io

Market cap
$5.0M
Open
Day range
Prev close
Volume
IPO date
Nov 10, 2021

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Bluejay Diagnostics, Inc..

Write a review
Explore

Similar companies

Browse all →